A new study conducted by the Harvard School of Public Health and the Alzheimer Europe suggests a strong consumer desire for "predictive testing" - the promise of a medical test that can gauge the likelihood of people falling in Alzheimer's disease (AD) as they age. More than two-thirds of respondents said they would like to have this kind of test of cognitive health screening available.
interesting question then is: What types of Alzheimer's disease screening tests are available? Screening tests fall into three main categories:
(1) Cognitive Assessments: is traditionally performed by a physician specialist (neuropsychologist, neurologist, etc.), these tests measure short-term memory (usually the first cognitive skills to succeed in early AD) and other important cognitive domains. There are also some recent computational cognitive screening tools that can be used in a doctor's office and other general practitioners and primary care settings such as Community Health Clinic.
major benefit of computer cognitive tests that can be applied by trained personnel office, but scarce as neuropsiholog.Kompjuterizirani tests also tend to be less time (20 minutes vs. 1 hour or more for traditional assessment), and are quite low cost. With the new Medicare Annual Wellness benefit now in place, after the effective way to check millions of patients each year will become increasingly important.
(2) biomarker tests: There is a lot of attention and controversy surrounding biomarker tests for Alzheimer's disease and dementia. News appears weekly on the latest research for a simple blood test, or more exotic choices such as a test fluid to predict the chances of Alzheimer's bolesti.Nacionalni Institute on Aging (NIA) and the Alzheimer's Association does not currently recommend the use of biomarker tests for the diagnosis of -. The right choice at this point, given the conflicting research data and the lack of standards in the screening of biomarkers for AD
(3) genetic testing: quite easy and simple to do today, but not very useful for the prediction of AD, from lifestyle and environmental variables play a large role in determining chances of Alzheimer's disease. The only exception: if there is a strong family history of early appearance of AD (65 years), also known as a family of Alzheimer's disease - a fad, then genetic testing should take into consideration the
.of public opinion polls, conducted in the United States, Germany, France, Spain and Poland, provides some very useful insights for health care and public policy communities.